Quantum Leap: Is pharma ready for the next computing revolution?
Partha Anbil, SVP, Life Sciences, at Coforge Limited, and Alex Kandybin, Founder of Quantum Wargaming, explore how quantum computing is… Read More
Partha Anbil, SVP, Life Sciences, at Coforge Limited, and Alex Kandybin, Founder of Quantum Wargaming, explore how quantum computing is… Read More
Yan Zhang, President of proteomic sciences at Thermo Fisher Scientific, writes about developments in precision medicine and how biobanks are key to … Read More
Steven Bulera, Corporate Vice President, Chief Scientific Officer: Safety Assessment, Charles River Laboratories, explores various use-cases of AI in improving drug discovery. It’s difficult, if not impossible, to escape the headlines and… Read More
Alistair Henry, Executive Vice President Chief Scientific Officer at UCB, explains that various factors that are helping drive the development of T-cell engagers (TCEs). … Read More
AI tech company Bioptimus has signed a partnership with one of France’s leading academic cancer research organisations in efforts to build an AI model of biology. The partnership with the Fédération Francophone de Cancérologie Digestive (FFCD) will grant Bioptimus access to a unique cohort of deeply phenotyped clinical trial data from more than 3,000 gastrointestinal (GI)… Read More
The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers uncovered clues explaining risks of heart disease, lung disease, Covid-19 and… Read More
It is especially difficult within the life sciences sector – and indeed everyday life – to avoid mentions of AI and the inevitable changes it will bring, and is bringing, to drug discovery. Further difficulty stems from the need to distinguish between hype, reality and fantasy. Drug discovery and… Read More
The latest issue of Drug Discovery World is out now. The DDW Summer 2026 issue examines the multi-compound approach to autism, the outlook for GLP-1 therapies and highlights drug discovery innovators and Investors – investment challenges and opportunities for drug developers. It also included features on: The importance of tech and collaboration for immunotherapies The… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, results showed the new Wegovy pill could help patients lose 17% of… Read More
News round-up for 15 June – 19 June by Bruno Quinney, Content Team at DDW. This week, results show the new Wegovy pill could help patients lose 17% of their body weight. Elsewhere, advances have been made in both cancer treatment and cancer research. The top stories: … Read More
Cancer Research UK is set to invest £17 million ($23 million) and create up to 100 new jobs in a boost to the charity’s Manchester Institute. The Cancer Research UK Manchester Institute will receive an additional £6 million ($8 million) on top of the original £11 million… Read More
DaltonTx has launched an AI drug discovery platform which could help scientists “make better-informed decisions earlier in the discovery process”. The platform, called Dalton, seeks to integrate agentic AI, human expertise and experimental data into a continuous learning engine. DaltonTx says the platform links molecules, assays, models, experimental outcomes, project context and human decisions… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a cancer drug demonstrated it could reduce tumours by as much as… Read More
News round-up for 1 June – 5 June by Bruno Quinney, Content Team at DDW. This week, a cancer drug has demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI has been a recurrent theme in both clinical trials and drug development. The top stories:… Read More
AI company Ingenix has announced it has raised €13 million to scale its drug development model. Ingenix says its Biological Reasoning Engine overcomes structural problems in AI drug development, integrating best-in-class models across modalities and biological scales. The model was applied to a dual-payload ADC prioritisation… Read More